Can a fitness tracker and coaching get teens with leukemia moving?
NCT ID NCT06182163
First seen Jun 25, 2026 · Last updated Jul 08, 2026 · Updated 3 times
Summary
This study tested whether a mobile health program—including a Fitbit with movement reminders, coaching sessions, and a WhatsApp peer support group—could help 20 adolescents and young adults with acute lymphoblastic leukemia (ALL) reduce the time they spend sitting or lying down during maintenance chemotherapy. The main goal was to see if the program was practical and acceptable to participants. Researchers also looked for early signs that it might improve quality of life, reduce inflammation, and help with metabolism.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- mobile health intervention (Fitbit, coaching, peer support)
- What this could lead to
- If it works, this could offer a practical way to help teens and young adults with ALL be less sedentary, potentially improving their quality of life and health during treatment.
- What could go wrong
- This is a very small feasibility trial with only 20 participants and no control group, so results may not apply broadly. The intervention may not be engaging enough to sustain long-term behavior change.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple blood draw could spare kids with leukemia from painful bone marrow tests
- Fighting sedentary time in young cancer patients: a digital intervention put to the test
- Can a smart drug missile tame Hard-to-Treat leukemia?
- Can targeted drugs blinatumomab and venetoclax improve outcomes for childhood leukemia?
- Epigenetic drugs aim to stop cancer return after transplant in kids
- Supercharged immune cells take aim at cancer and viruses in one shot